StatSure Diagnostic Systems, Inc. (SDS) is primarily engaged in commercializing two product platforms: the development, manufacturing and marketing of oral-fluid collection devices to provide physiologic samples to screen for the presence of drugs-of-abuse or infectious diseases, and the development of point-of-care (POC) immunoassays for use in the detection of infectious diseases. As part of a three-way alliance with Inverness Medical Innovations, Inc. and Chembio Diagnostics, SDS signed a worldwide, distribution deal for a point-of-care human immunodeficiency virus (HIV) test with Inverness. In a two-way deal with Chembio, the Company granted a license to Chembio solely to manufacture their United States Food and Drug Administration (FDA)-approved HIV barrel product for Inverness Medical Innovations. This product is being marketed under the IMA brand.
(Source: 10KSB)
